CD4 t cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of vzv infection

Kristen Haberthur, Flora Engelmann, Byung Park, Alex Barron, Alfred Legasse, Jesse Dewane, Miranda Fischer, Amelia Kerns, Monica Brown, Ilhem Messaoudi

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Primary infection with varicella zoster virus (VZV) results in varicella (more commonly known as chickenpox) after which VZV establishes latency in sensory ganglia. VZV can reactivate to cause herpes zoster (shingles), a debilitating disease that affects one million individuals in the US alone annually. Current vaccines against varicella (Varivax) and herpes zoster (Zostavax) are not 100% efficacious. Specifically, studies have shown that 1 dose of varivax can lead to breakthrough varicella, albeit rarely, in children and a 2-dose regimen is now recommended. Similarly, although Zostavax results in a 50% reduction in HZ cases, a significant number of recipients remain at risk. To design more efficacious vaccines, we need a better understanding of the immune response to VZV. Clinical observations suggest that T cell immunity plays a more critical role in the protection against VZV primary infection and reactivation. However, no studies to date have directly tested this hypothesis due to the scarcity of animal models that recapitulate the immune response to VZV. We have recently shown that SVV infection of rhesus macaques models the hallmarks of primary VZV infection in children. In this study, we used this model to experimentally determine the role of CD4, CD8 and B cell responses in the resolution of primary SVV infection in unvaccinated animals. Data presented in this manuscript show that while CD20 depletion leads to a significant delay and decrease in the antibody response to SVV, loss of B cells does not alter the severity of varicella or the kinetics/magnitude of the T cell response. Loss of CD8 T cells resulted in slightly higher viral loads and prolonged viremia. In contrast, CD4 depletion led to higher viral loads, prolonged viremia and disseminated varicella. CD4 depleted animals also had delayed and reduced antibody and CD8 T cell responses. These results are similar to clinical observations that children with agammaglobulinemia have uncomplicated varicella whereas children with T cell deficiencies are at increased risk of progressive varicella with significant complications. Moreover, our studies indicate that CD4 T cell responses to SVV play a more critical role than antibody or CD8 T cell responses in the control of primary SVV infection and suggest that one potential mechanism for enhancing the efficacy of VZV vaccines is by eliciting robust CD4 T cell responses.

Original languageEnglish (US)
Article numbere1002367
JournalPLoS Pathogens
Volume7
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Human Herpesvirus 3
Chickenpox
Virus Diseases
Primates
Immunity
Chickenpox Vaccine
T-Lymphocytes
Herpes Zoster Vaccine
Infection
Herpes Zoster
Viremia
Viral Load
B-Lymphocytes
Virus Latency
Sensory Ganglia
Agammaglobulinemia
Antibodies
Macaca mulatta
Antibody Formation
Vaccines

ASJC Scopus subject areas

  • Microbiology
  • Parasitology
  • Virology
  • Immunology
  • Genetics
  • Molecular Biology

Cite this

CD4 t cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of vzv infection. / Haberthur, Kristen; Engelmann, Flora; Park, Byung; Barron, Alex; Legasse, Alfred; Dewane, Jesse; Fischer, Miranda; Kerns, Amelia; Brown, Monica; Messaoudi, Ilhem.

In: PLoS Pathogens, Vol. 7, No. 11, e1002367, 11.2011.

Research output: Contribution to journalArticle

Haberthur, K, Engelmann, F, Park, B, Barron, A, Legasse, A, Dewane, J, Fischer, M, Kerns, A, Brown, M & Messaoudi, I 2011, 'CD4 t cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of vzv infection', PLoS Pathogens, vol. 7, no. 11, e1002367. https://doi.org/10.1371/journal.ppat.1002367
Haberthur, Kristen ; Engelmann, Flora ; Park, Byung ; Barron, Alex ; Legasse, Alfred ; Dewane, Jesse ; Fischer, Miranda ; Kerns, Amelia ; Brown, Monica ; Messaoudi, Ilhem. / CD4 t cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of vzv infection. In: PLoS Pathogens. 2011 ; Vol. 7, No. 11.
@article{b80fc109e49f44e38605ec0603ce891d,
title = "CD4 t cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of vzv infection",
abstract = "Primary infection with varicella zoster virus (VZV) results in varicella (more commonly known as chickenpox) after which VZV establishes latency in sensory ganglia. VZV can reactivate to cause herpes zoster (shingles), a debilitating disease that affects one million individuals in the US alone annually. Current vaccines against varicella (Varivax) and herpes zoster (Zostavax) are not 100{\%} efficacious. Specifically, studies have shown that 1 dose of varivax can lead to breakthrough varicella, albeit rarely, in children and a 2-dose regimen is now recommended. Similarly, although Zostavax results in a 50{\%} reduction in HZ cases, a significant number of recipients remain at risk. To design more efficacious vaccines, we need a better understanding of the immune response to VZV. Clinical observations suggest that T cell immunity plays a more critical role in the protection against VZV primary infection and reactivation. However, no studies to date have directly tested this hypothesis due to the scarcity of animal models that recapitulate the immune response to VZV. We have recently shown that SVV infection of rhesus macaques models the hallmarks of primary VZV infection in children. In this study, we used this model to experimentally determine the role of CD4, CD8 and B cell responses in the resolution of primary SVV infection in unvaccinated animals. Data presented in this manuscript show that while CD20 depletion leads to a significant delay and decrease in the antibody response to SVV, loss of B cells does not alter the severity of varicella or the kinetics/magnitude of the T cell response. Loss of CD8 T cells resulted in slightly higher viral loads and prolonged viremia. In contrast, CD4 depletion led to higher viral loads, prolonged viremia and disseminated varicella. CD4 depleted animals also had delayed and reduced antibody and CD8 T cell responses. These results are similar to clinical observations that children with agammaglobulinemia have uncomplicated varicella whereas children with T cell deficiencies are at increased risk of progressive varicella with significant complications. Moreover, our studies indicate that CD4 T cell responses to SVV play a more critical role than antibody or CD8 T cell responses in the control of primary SVV infection and suggest that one potential mechanism for enhancing the efficacy of VZV vaccines is by eliciting robust CD4 T cell responses.",
author = "Kristen Haberthur and Flora Engelmann and Byung Park and Alex Barron and Alfred Legasse and Jesse Dewane and Miranda Fischer and Amelia Kerns and Monica Brown and Ilhem Messaoudi",
year = "2011",
month = "11",
doi = "10.1371/journal.ppat.1002367",
language = "English (US)",
volume = "7",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - CD4 t cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of vzv infection

AU - Haberthur, Kristen

AU - Engelmann, Flora

AU - Park, Byung

AU - Barron, Alex

AU - Legasse, Alfred

AU - Dewane, Jesse

AU - Fischer, Miranda

AU - Kerns, Amelia

AU - Brown, Monica

AU - Messaoudi, Ilhem

PY - 2011/11

Y1 - 2011/11

N2 - Primary infection with varicella zoster virus (VZV) results in varicella (more commonly known as chickenpox) after which VZV establishes latency in sensory ganglia. VZV can reactivate to cause herpes zoster (shingles), a debilitating disease that affects one million individuals in the US alone annually. Current vaccines against varicella (Varivax) and herpes zoster (Zostavax) are not 100% efficacious. Specifically, studies have shown that 1 dose of varivax can lead to breakthrough varicella, albeit rarely, in children and a 2-dose regimen is now recommended. Similarly, although Zostavax results in a 50% reduction in HZ cases, a significant number of recipients remain at risk. To design more efficacious vaccines, we need a better understanding of the immune response to VZV. Clinical observations suggest that T cell immunity plays a more critical role in the protection against VZV primary infection and reactivation. However, no studies to date have directly tested this hypothesis due to the scarcity of animal models that recapitulate the immune response to VZV. We have recently shown that SVV infection of rhesus macaques models the hallmarks of primary VZV infection in children. In this study, we used this model to experimentally determine the role of CD4, CD8 and B cell responses in the resolution of primary SVV infection in unvaccinated animals. Data presented in this manuscript show that while CD20 depletion leads to a significant delay and decrease in the antibody response to SVV, loss of B cells does not alter the severity of varicella or the kinetics/magnitude of the T cell response. Loss of CD8 T cells resulted in slightly higher viral loads and prolonged viremia. In contrast, CD4 depletion led to higher viral loads, prolonged viremia and disseminated varicella. CD4 depleted animals also had delayed and reduced antibody and CD8 T cell responses. These results are similar to clinical observations that children with agammaglobulinemia have uncomplicated varicella whereas children with T cell deficiencies are at increased risk of progressive varicella with significant complications. Moreover, our studies indicate that CD4 T cell responses to SVV play a more critical role than antibody or CD8 T cell responses in the control of primary SVV infection and suggest that one potential mechanism for enhancing the efficacy of VZV vaccines is by eliciting robust CD4 T cell responses.

AB - Primary infection with varicella zoster virus (VZV) results in varicella (more commonly known as chickenpox) after which VZV establishes latency in sensory ganglia. VZV can reactivate to cause herpes zoster (shingles), a debilitating disease that affects one million individuals in the US alone annually. Current vaccines against varicella (Varivax) and herpes zoster (Zostavax) are not 100% efficacious. Specifically, studies have shown that 1 dose of varivax can lead to breakthrough varicella, albeit rarely, in children and a 2-dose regimen is now recommended. Similarly, although Zostavax results in a 50% reduction in HZ cases, a significant number of recipients remain at risk. To design more efficacious vaccines, we need a better understanding of the immune response to VZV. Clinical observations suggest that T cell immunity plays a more critical role in the protection against VZV primary infection and reactivation. However, no studies to date have directly tested this hypothesis due to the scarcity of animal models that recapitulate the immune response to VZV. We have recently shown that SVV infection of rhesus macaques models the hallmarks of primary VZV infection in children. In this study, we used this model to experimentally determine the role of CD4, CD8 and B cell responses in the resolution of primary SVV infection in unvaccinated animals. Data presented in this manuscript show that while CD20 depletion leads to a significant delay and decrease in the antibody response to SVV, loss of B cells does not alter the severity of varicella or the kinetics/magnitude of the T cell response. Loss of CD8 T cells resulted in slightly higher viral loads and prolonged viremia. In contrast, CD4 depletion led to higher viral loads, prolonged viremia and disseminated varicella. CD4 depleted animals also had delayed and reduced antibody and CD8 T cell responses. These results are similar to clinical observations that children with agammaglobulinemia have uncomplicated varicella whereas children with T cell deficiencies are at increased risk of progressive varicella with significant complications. Moreover, our studies indicate that CD4 T cell responses to SVV play a more critical role than antibody or CD8 T cell responses in the control of primary SVV infection and suggest that one potential mechanism for enhancing the efficacy of VZV vaccines is by eliciting robust CD4 T cell responses.

UR - http://www.scopus.com/inward/record.url?scp=81755187231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81755187231&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1002367

DO - 10.1371/journal.ppat.1002367

M3 - Article

C2 - 22102814

AN - SCOPUS:81755187231

VL - 7

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 11

M1 - e1002367

ER -